These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6150856)

  • 21. I1 receptors, cardiovascular function, and metabolism.
    Bousquet P
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):317S-321S. PubMed ID: 11721890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentration-effect relationships of two infusion rates of the imidazoline antihypertensive agent rilmenidine for blood pressure and development of side-effects in healthy subjects.
    de Visser SJ; van Gerven JM; Schoemaker RC; Cohen AF
    Br J Clin Pharmacol; 2001 May; 51(5):423-8. PubMed ID: 11421999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular and central nervous system effects of rilmenidine (S 3341) in rats.
    Koenig-Berard E; Tierney C; Beau B; Delbarre G; Lhoste F; Labrid C
    Am J Cardiol; 1988 Feb; 61(7):22D-31D. PubMed ID: 2894153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in the pharmacology of rilmenidine.
    Montastruc JL; Macquin-Mavier I; Tran MA; Damase-Michel C; Koenig-Berard E; Valet P
    Am J Med; 1989 Sep; 87(3C):14S-17S. PubMed ID: 2571291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine and rilmenidine suppress hypotension-induced Fos expression in the lower brainstem of the conscious rabbit.
    Li YW; Dampney RA
    Neuroscience; 1995 May; 66(2):391-402. PubMed ID: 7477880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rilmenidine: a novel antihypertensive agent.
    Safar ME
    Am J Med; 1989 Sep; 87(3C):24S-29S. PubMed ID: 2571292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current data on the pharmacology of rilmenidine].
    Montastruc JL; Macquin-Mavier I; Damase-Michel C; Dard B; Tran MA; Valet P
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():25-9. PubMed ID: 2517006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.
    Macphee GJ; Howie CA; Elliott HL; Reid JL
    Br J Clin Pharmacol; 1992 Mar; 33(3):261-7. PubMed ID: 1576046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors.
    Tibiriça E; Feldman J; Mermet C; Monassier L; Gonon F; Bousquet P
    Eur J Pharmacol; 1991 Dec; 209(3):213-21. PubMed ID: 1686768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
    Gomez RE; Ernsberger P; Feinland G; Reis DJ
    Eur J Pharmacol; 1991 Mar; 195(2):181-91. PubMed ID: 1651861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imidazoline receptors. A new concept in central regulation of the arterial blood pressure.
    Bousquet P; Feldman J; Tibirica E; Bricca G; Greney H; Dontenwill M; Stutzmann J; Belcourt A
    Am J Hypertens; 1992 Apr; 5(4 Pt 2):47S-50S. PubMed ID: 1350728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rilmenidine and vigilance. Review of clinical studies.
    Mahieux F
    Am J Med; 1989 Sep; 87(3C):67S-72S. PubMed ID: 2571296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rilmenidine reveals differences in the pharmacological characteristics of prejunctional alpha2-adrenoceptors in the guinea-pig, rat and pig.
    Ali A; Cheng HY; Ting KN; Wilson VG
    Br J Pharmacol; 1998 Sep; 125(1):127-35. PubMed ID: 9776352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of acute and chronic treatment with an adrenergic alpha receptor agonist, LE S3341, on the rate of catecholamine turnover in various peripheral organs and brain structures in the rat].
    Rochette L; Beley A; Bralet J
    J Pharmacol; 1986; 17(4):567-77. PubMed ID: 2882066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.
    Evans RG; Anderson WP
    Br J Pharmacol; 1995 Sep; 116(1):1557-70. PubMed ID: 8564219
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of continuous infusions (10 days) and cessation of infusions of clonidine and rilmenidine (S 3341) on cardiovascular and behavioral parameters of spontaneously hypertensive rats.
    Jarrott B; Lewis SJ; Doyle AE; Louis WJ
    Am J Cardiol; 1988 Feb; 61(7):39D-44D. PubMed ID: 2894156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.